Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftElisabettaCameroni, ChristianSaliba, John E.Bowen, Laura E.Rosen, KatjaCulap, DoraPinto, Laura A.VanBlargan, AnnaDe Marco, Samantha K.Zepeda, Julia diIulio, FabriziaZatta, HannahKaiser, JuliaNoack, NisarFarhat, NadineCzudnochowski, ColinHavenar-Daughton, Kaitlin R.Sprouse, Josh R.Dillen, Abigail E.Powell, AlexChen, CyrusMaher, LiYin, DavidSun, LeahSoriaga, JessicaBassi, ChiaraSilacci-Fregni, ClaesGustafsson, Nicholas M.Franko, JenniLogue, Najeeha TalatIqbal, IgnacioMazzitelli, JorgeGeffner, RenataGrifantini, HelenChu, AndreaGori, AgostinoRiva, OlivierGiannini, AlessandroCeschi, PaoloFerrari, PietroCippà, AlessandraFranzetti-Pellanda, ChristianGarzoni, Peter J.Halfmann, YoshihiroKawaoka, ChristyHebner, Lisa A.Purcell, LucaPiccoli, Matteo SamuelePizzuto, Alexandra C.Walls, Michael S.Diamond, AmalioTelenti, Herbert W.Virgin, AntonioLanzavecchia, DavidVeesler, GyorgySnell, DavideCorti
bioRxiv 2021.12.12.472269; doi: https://doi.org/10.1101/2021.12.12.472269
